ArticleMicrobiology spectrum2026
Evaluation of Oxford nanopore sequencing for antimicrobial resistance surveillance in
Yu-Ping Hong, Ying-Shu Liao, You-Wun Wang, Shao-Chun Kuo, Ru-Hsiou Teng, Shiu-Yun Liang, Jui-Hsien Chang, Hsiao Lun Wei, Chien-Shun Chiou
Abstract readComparative Study
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yu-Ping Hong *Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.ORCID 0000-0003-2249-7364 Ying-Shu Liao *Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
You-Wun WangCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.ORCID 0009-0002-2104-0872 Shao-Chun KuoCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
Ru-Hsiou TengCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
Shiu-Yun LiangCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
Jui-Hsien ChangCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
Hsiao Lun WeiCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.
Chien-Shun ChiouCenter for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taichung, Taiwan.ORCID 0000-0003-3674-1030 Funding
Ministry of Health and Welfare MOHW113-CDC-C-315-114110, MOHW114-CDC-C-315-124112, MOHW115-CDC-C-305-134118Ministry of Health and Welfare MOHW115-CDC-C-305-114304
6 · The paper itselfAbstract
IMPORTANCE: Accurate prediction of antimicrobial resistance is essential for appropriate therapy and effective surveillance of
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialNanopore SequencingSalmonellaSalmonella InfectionsGenome, BacterialGenotypeHumansMicrobial Sensitivity TestsPhenotypeTaiwanThird Generation CephalosporinsWhole Genome SequencingAnti-Bacterial AgentsThird Generation Cephalosporinsantimicrobial resistance (AMR)antimicrobial susceptibility testing (AST)non-typhoidal Salmonella (NTS)Oxford nanopore sequencingwhole-genome sequencing (WGS)
Identifiers
PMID42584076
PMCPMC13532270
What OpenQuestion holds
Textmetadata
Read underepoch 390